SE447450B - Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa - Google Patents

Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa

Info

Publication number
SE447450B
SE447450B SE8100104A SE8100104A SE447450B SE 447450 B SE447450 B SE 447450B SE 8100104 A SE8100104 A SE 8100104A SE 8100104 A SE8100104 A SE 8100104A SE 447450 B SE447450 B SE 447450B
Authority
SE
Sweden
Prior art keywords
tablet
starch
amount
pharmaceutical composition
cellulose
Prior art date
Application number
SE8100104A
Other languages
English (en)
Swedish (sv)
Other versions
SE8100104L (sv
Inventor
J M Dunn
J F Lampard
Original Assignee
Boots Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/194,453 external-priority patent/US4308251A/en
Application filed by Boots Co Ltd filed Critical Boots Co Ltd
Publication of SE8100104L publication Critical patent/SE8100104L/
Publication of SE447450B publication Critical patent/SE447450B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8100104A 1980-01-11 1981-01-09 Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa SE447450B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11143080A 1980-01-11 1980-01-11
US06/194,453 US4308251A (en) 1980-01-11 1980-10-17 Controlled release formulations of orally-active medicaments

Publications (2)

Publication Number Publication Date
SE8100104L SE8100104L (sv) 1981-07-12
SE447450B true SE447450B (sv) 1986-11-17

Family

ID=26808896

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8100104A SE447450B (sv) 1980-01-11 1981-01-09 Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa

Country Status (22)

Country Link
JP (1) JPS56103110A (el)
AT (1) AT374681B (el)
AU (1) AU542824B2 (el)
BE (1) BE886998A (el)
CA (1) CA1140466A (el)
CH (1) CH646604A5 (el)
DE (1) DE3100191A1 (el)
DK (1) DK6181A (el)
ES (2) ES498369A0 (el)
FI (1) FI76927C (el)
FR (1) FR2473308B1 (el)
GB (1) GB2067072B (el)
GR (1) GR73843B (el)
IE (1) IE50806B1 (el)
IN (1) IN151913B (el)
IT (1) IT1221041B (el)
LU (1) LU83052A1 (el)
NL (1) NL8100037A (el)
NO (1) NO156153C (el)
NZ (1) NZ195933A (el)
SE (1) SE447450B (el)
ZA (1) ZA81136B (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2496082A (en) * 1947-05-24 1950-01-31 Ashenfelter William Scaffold structure
IT1144911B (it) * 1981-03-19 1986-10-29 Pharmatec Spa Composizione farmaceutica a rilascio controllato contenente ibuprofen
JPS59227817A (ja) * 1983-06-07 1984-12-21 Toyo Jozo Co Ltd 持続性経口用ブレデニン製剤
JPH0662404B2 (ja) * 1983-06-14 1994-08-17 シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド 制御放出性ナプロキセンおよびナプロキセンナトリウム錠
ZA836030B (en) * 1983-08-16 1985-02-27 Verex Lab Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions
ZA836031B (en) * 1983-08-16 1985-02-27 Verex Lab Constant release rate solid dosage theophylline formulation
DE3486029T2 (de) * 1983-10-14 1993-05-13 Sumitomo Pharma Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung.
US5385738A (en) * 1983-10-14 1995-01-31 Sumitomo Pharmaceuticals Company, Ltd. Sustained-release injection
US4774091A (en) * 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
DE3688188T2 (de) * 1985-12-27 1993-10-14 Koken Kk Verfahren zur Herstellung einer Formulierung mit verzögerter Freisetzung.
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4968508A (en) * 1987-02-27 1990-11-06 Eli Lilly And Company Sustained release matrix
IL85538A (en) * 1987-02-27 1991-09-16 Lilly Co Eli Sustained release matrix tablet formulations containing hydrophilic and enteric polymers
WO1997002019A1 (en) * 1995-06-30 1997-01-23 Baylor University Polyester/carboxylic acid composite materials

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2953497A (en) * 1953-06-03 1960-09-20 Howard A Press Therapeutic tablets
NL265428A (el) * 1960-06-06
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
US3906086A (en) * 1971-07-19 1975-09-16 Richard G Powers Timed-release aspirin
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS5411226A (en) * 1977-06-24 1979-01-27 Shin Etsu Chem Co Ltd Disintegratable granule

Also Published As

Publication number Publication date
FI76927B (fi) 1988-09-30
GB2067072A (en) 1981-07-22
SE8100104L (sv) 1981-07-12
NO810062L (no) 1981-07-13
BE886998A (fr) 1981-07-08
AT374681B (de) 1984-05-25
FI810056L (fi) 1981-07-12
CA1140466A (en) 1983-02-01
DE3100191A1 (de) 1981-12-10
FI76927C (fi) 1989-01-10
FR2473308B1 (fr) 1985-07-19
IT1221041B (it) 1990-06-21
NL8100037A (nl) 1981-08-03
DE3100191C2 (el) 1988-09-01
LU83052A1 (fr) 1982-09-10
ES8205353A1 (es) 1982-06-01
DK6181A (da) 1981-07-12
ES509179A0 (es) 1982-12-16
ZA81136B (en) 1982-01-27
GB2067072B (en) 1983-08-10
ES8301629A1 (es) 1982-12-16
IE50806B1 (en) 1986-07-23
ATA5481A (de) 1983-10-15
NZ195933A (en) 1982-11-23
IE810036L (en) 1981-07-11
IT8147537A0 (it) 1981-01-09
NO156153C (no) 1987-08-05
FR2473308A1 (fr) 1981-07-17
NO156153B (no) 1987-04-27
ES498369A0 (es) 1982-06-01
GR73843B (el) 1984-05-07
CH646604A5 (fr) 1984-12-14
JPS56103110A (en) 1981-08-18
IN151913B (el) 1983-09-03
AU6597681A (en) 1981-07-16
AU542824B2 (en) 1985-03-14

Similar Documents

Publication Publication Date Title
SE447450B (sv) Farmaceutiska kompositioner med ihallande frigoring i tabellform samt sett att framstella dessa
EP0652747B1 (en) Controlled release morphine preparation
US5529783A (en) Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan
US3632739A (en) Solid sustained release pharmaceutical preparation
JPH08500110A (ja) ブプロピオン含有持続放出型錠剤
JPS63107917A (ja) イブプロフエン徐放性製剤およびその製造方法
KR930008956B1 (ko) 서방형 이부프로펜 제제의 제조방법
JP2849047B2 (ja) ジクロフェナクナトリウム持続性製剤およびその製法
AU2002213900A1 (en) Pharmaceutical compositions
WO2002020090A2 (en) Pharmaceutical compositions
JP2007055924A (ja) イブプロフェン及び塩酸アンブロキソール含有固形製剤
EP0025686B1 (en) Pharmaceutical composition containing paracetamol, treatment pack comprising said composition and method of reducing liver toxicity effect of paracetamol compositions
WO2003059323A2 (de) Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren ii
JPH0920663A (ja) イブジラストを含有する徐放性細粒剤およびその製法
AU2014295099A1 (en) Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation
GB2142823A (en) Sustained release indomethacin or niomethacin formulations
JP2003221326A (ja) 分岐鎖アミノ酸を含有するチュアブル剤
JPH0797325A (ja) 安定な固形製剤およびその製造法
JPS6087217A (ja) 一定放出速度の固体調剤テオフイリン配合物
KR930011993B1 (ko) 지속성-방출형 약학적 조성물 및 그 제조방법
JPH11322584A (ja) ベザフィブラート徐放性製剤
JP2006328001A (ja) 経口投与用製剤
JPH03184917A (ja) 安定なビタミンｄ↓３類含有製剤
JPH06279275A (ja) エカベトナトリウム含有経口投与用製剤
JP2000169367A (ja) メキタジン含有内服固形製剤

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8100104-2

Effective date: 19901211

Format of ref document f/p: F